Parikshit Somani Banned for Four Years: Trimetazidine, the Valieva Blueprint and the Limits of an Unknown Name

Parikshit Somani Banned for Four Years: Trimetazidine, the Valieva Blueprint and the Limits of an Unknown Name

On Wednesday, from London, the International Tennis Integrity Agency (ITIA) announced a four-year ban for Parikshit Somani. The 26-year-old Indian player cannot return until September 2029. The sanction reaches so far that he may not play, may not coach, and may not even attend any event organised by World Tennis, the WTA, the ATP, the Grand Slams or any national federation.

What made me stop at that line was not the number four. It was the name. Somani has never climbed past No. 256 in the doubles rankings. He belongs to the group of players whose faces the stands do not remember, whose names announcers never read out, and to whom broadcasters give not a single camera. And in precisely that invisible group, one positive sample carries the same weight as an Olympic champion's.

I have spent years sitting in dark rooms, rewinding frames nobody wants to watch. There is one principle I learned from that work, and it holds in a laboratory too: when the evidence has no one to speak for it, it must stand on its own. Somani had no one to speak for him. No heavyweight lawyer, no communications team, no public opinion large enough to demand mercy.

Context: one molecule, three names, eleven years

Somani tested positive for trimetazidine at a lower-tier event in Astana, Kazakhstan, in 2026. Trimetazidine is an active substance found in cardiac medications, banned in sport for its capacity to improve performance and to mask signs of cardiac ischemia under exertion.

The name trimetazidine did not first appear in sport here. It was the substance at the centre of the Kamila Valieva case — which flared at the Beijing 2026 Winter Olympics and ended with a four-year ban for the Russian figure skater. Earlier, in 2026, Chinese swimmer Sun Yang also tested positive for the same substance.

Three athletes, three sports, three different governing systems, one molecule. This is the point I want readers to hold onto before the rest: trimetazidine is not an exotic substance. It sits in the medicine cabinets of millions of households, and precisely for that reason it is the substance where a contamination explanation appears most often.

At an August hearing, Somani explained his positive test as contamination from food prepared by a family member, whose medicine got into what he ate. The ITIA said the independent tribunal could not verify the source of the alleged contamination. The judges concluded the food contamination theories were “scientifically implausible”, “highly speculative” and “unconvincing”.

The ITIA is the body responsible for investigating and prosecuting match-fixing and doping violations in professional tennis, working with the ATP, the WTA, the ITF and the Grand Slams. The tribunal in Somani's case was independent, and this detail matters: no federation handed down the sanction directly. A group of people nobody can name read the file, heard the defence, and signed the decision.

The defence template has become a formula

Set Somani's defence structure beside the defence structure in the Valieva case and the overlap is not coincidence — it is the same shape.

That frame has three layers. Layer one: acknowledge a substance was in the body. Layer two: deny intentional use. Layer three: point to a contamination source outside your control — food, drink, a relative's medicine, a skin cream, a supplement.

The problem with layer three is not whether it is true. It is that it is almost impossible to prove. To prove it, an athlete must identify the specific dish, the specific cook, the specific pill, the specific moment, and a physical pathway by which the molecule travelled from a medicine cabinet into their body. Even when the story is true, reconstructing it as scientific evidence is a near-impossible task.

The tribunal did not say Somani lied. It said three other words: not convincing. The gap between those two statements is the entire tragedy of anti-doping law, and it is the thing most spectators never distinguish.

I once sat in a windowless room in Hai Phong at two in the morning, rewinding a passage of play hundreds of times, purely to determine whether ball met hand. The final conclusion was: not enough to conclude. In VAR we have a phrase for that state — inconclusive evidence. It does not mean the player is innocent. It only means we lack the data to convict. In a doping courtroom, that standard is inverted: the athlete must prove their innocence, rather than the organisation proving guilt.

That is the deepest difference between a VAR room and a laboratory: in football, the evidence belongs to the governing body; in doping, the burden belongs to the athlete.

The arithmetic of a sanction

Four years. Place that number beside a tennis career.

Somani was born in 2026 and is 26. He will be 30 when the ban ends in September 2029. In the doubles rankings, his career peak is No. 256 — a number most fans cannot place between No. 1 and No. 1000.

How does a doubles player ranked around 250 live? On Challenger and ITF events, where the prize money for a win can be less than the airfare and the hotel bill combined. By splitting every payment with a partner. By accepting two-leg connecting flights to save a few hundred dollars. By booking his own practice court, hiring his own hitting partner, buying his own wrist tape.

Then one positive sample, and the whole fragile structure collapses inside a press release.

A four-year ban is not a labour penalty. It is an identity penalty. After four years, no ranking holds position 256 for him. No doubles partner is waiting. No tournament director is holding a wildcard. In tennis, a long suspension is equivalent to retirement, differing only in that it does not let him call it that.

A player ranked 256 banned for four years will not come back. A Grand Slam champion banned for four years can come back and still be invited to exhibitions. Same rule, different consequence — and no tribunal writes that into the record.

The contrarian angle: when a true explanation still loses

Here I want to step away from the crowd.

The easiest reaction, and the most comfortable one, is to say: he cheated, the ban fits, case closed. But if I am asked for a judgement I can stand behind, I cannot stop there.

What the tribunal rejected was the contamination theory in this specific case. It did not reject the possibility of trimetazidine contamination in general — because that possibility is real, and every sports scientist knows it. What was rejected was the specific version Somani offered, without measurable evidence attached.

Which means a gap exists: a person can have genuinely been contaminated and still lose their case, because they lacked the resources to rebuild their truth into a scientific file. That gap is not written in the rules. It lives in the fact that the rules are applied to people with wildly unequal access to legal help.

Valieva had an international legal team, an Olympic committee, a state behind her. What did Somani have? An August hearing and a statement a few paragraphs long.

I am not saying Somani is innocent. I am saying the current system makes the chance of being exonerated proportional to how much money you have. And when fairness depends on budget, it stops being fairness — it becomes a service.

But I do not stand on the other side either. If a tribunal accepted a food explanation without evidence, then within twelve months every doping case in tennis would end with the sentence my mother cooked it. A system cannot run on trust. It can only run on proof.

This is a real contradiction, and it has no elegant answer. The biggest mistake is not blowing the whistle, but refusing to own your whistle. Here the whistle was blown correctly under the rules — but the rules were written for a field on which not everyone starts from the same line.

What I see when I rewind

In my years working with image-review systems, I learned there are two kinds of justice. The first is visible justice: it appears on the big screen, the stands see it, commentators name it. The second is justice behind closed doors: it happens where there is no audience, and it decides the fate of people who have no audience.

There are offside errors nobody sees, but the camera never blinks. In football, I am the man sitting behind that camera. In tennis, the people sitting behind that camera are a lab technician in Astana, an independent tribunal member in London, an ITIA staffer reading a file at midnight.

They are not named. Somani was not named either — until today, when he was named in the worst possible way.

I once spotted an offside that nobody in the stadium saw, and I received no thanks, because the coaching staff never knew I had intervened. I learned to accept that. But there is one thing I do not accept: that a player ranked 256 is processed by exactly the same procedure as a champion, when their capacity to defend themselves is a whole sky apart.

The referee is the only person on the pitch not allowed to pick a side — and I stand behind them. But standing behind them does not mean I am forbidden from seeing the distance between two people judged by the same clause.

What should change

The Somani case will not generate a big debate. No famous name, no medal, no nation demanding justice. It will pass in silence, exactly as it arrived.

But there are three things tennis's governing bodies could do, and none of them requires a long meeting.

First, a legal support fund for players outside the top 200. The issue is not generosity. The issue is that an identical evidentiary standard is being applied to people with very different capacities to meet it.

Second, publish the criteria used to assess contamination theories. If a specific concentration threshold is treated as consistent with contamination, publish that threshold. When the standard is unpublished, the decision becomes a black box — and black boxes cannot be audited.

Third, record and publish the work of independent tribunals in a searchable form. I believe in the same principle I believe in inside a VAR room: if nobody can review it, nobody is accountable.

I learned one thing from those nights rewinding frames alone, after everyone had gone home: justice rarely arrives in a dramatic moment. It arrives in dull, repeated reviews that nobody watches. Trimetazidine is not a glamorous molecule. Parikshit Somani is not a glamorous name. And quite possibly, real fairness in this sport will never be glamorous either.

It will simply be a process written correctly, applied evenly, and not tilted toward those with a legal team. If tennis wants to prove its sanctions mean something, this is the moment to prove it — with a name nobody remembers.